Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
InBoTox: Endoscopic intragastric botulinum toxin in obese patients awaiting bariatric surgery
2015-004391-29Phase 3Completed
- Sponsor
- Fundación IMABIS
- Start
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of botulinum toxin type A in class III obesity, sponsored by Fundación IMABIS. Primary endpoint: Preoperative weight loss. Started Feb 2016; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
class III obesity
Beyond the preview
Go deeper on 2015-004391-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004391-29.